Tag: Anders Bjartell
EAU Research Foundation explores new areas for collaboration and trials
The EAU Research Foundation has had new leadership since EAU17 in London, earlier this year. The existing board members retired to advisory roles within the EAU-RF and new members came in under the leadership of Prof. Anders Bjartell, the...
“Prioritise prospective studies and real-world data”
The EAU Research Foundation is uniquely placed to conduct and coordinate important prospective trials in the coming years, its new chairman has told European Urology Today. Prof. Anders Bjartell (Malmö, SE) took over chairmanship of the EAU Research Foundation...
EAU17: Thematic Session explores personalised medicine in prostate cancer
Knowledge of overexpressed oncogenes and the importance of the transcription factor ETS-related gene (ERG) and cytokines in relation to individualised therapy in prostate cancer, were examined today during the “Personalised medicine in urological oncology” session chaired by Prof. Zoran Culig...
EMUC16: Experts tackle combined therapies in prostate cancer
Systemic treatments and optimizing various forms of therapies in high-risk and metastatic forms of prostate cancer were examined at the first-day plenary session of the 8th European Meeting on Urological Cancers (EMUC16) which opened today in Milan, Italy. With...
EAU-ICUD Consensus Meeting: strategies in immunotherapy and chemotherapy of PCa
Cancer experts discussed the prospects and pitfalls in current management strategies in prostate cancer particularly those involving emergent treatments such as immunotherapy and standard medical options represented by chemotherapy. At the second-half of the day-long EAU-ICUD Consensus Meeting on...
PCTRE Meeting in Malmö looks at PCa research, treatment future
Future research collaborations within prostate cancer, and how they will be funded were discussed at Prostate Cancer Translational Research in Europe Meeting (PCTRE) in Malmö, Sweden. New cutting-edge research was also presented, with a particular focus on clinically useful...
PCTRE Meeting: Two-way communication between bench and clinic
On 27-28 June 2013, the Swedish city of Malmö will host the 2nd Meeting on Prostate Cancer Translational Research in Europe. This meeting is truly unique as it fosters the vital cooperation between basic research and practice, offering multiple...
Promising but mixed prospects for systemic therapy in urological cancers
There are emerging and promising treatment options for urological cancers, but major advances in prostate, kidney and bladder cancers are still beyond reach due to the lack of solid data, serious side-effects and some drawbacks in combination drug trials....